Highlights and Quick Summary
- Cash per Share for the quarter ending June 30, 2023 was 5.42 (a -3.97% decrease compared to previous quarter)
- Year-over-year quarterly Cash per Share decreased by -12.22%
- Annual Cash per Share for 2022 was 5.93 (a -29.07% decrease from previous year)
- Annual Cash per Share for 2021 was 8.36 (a 265.95% increase from previous year)
- Annual Cash per Share for 2020 was 2.28 (a 163092.86% increase from previous year)
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Cash per Share of Design Therapeutics, Inc.
Most recent Cash per Shareof DSGN including historical data for past 10 years.Interactive Chart of Cash per Share of Design Therapeutics, Inc.
Design Therapeutics, Inc. Cash per Share for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 5.42 | 5.64 | – | – | – |
| 2022 | 5.93 | 6.17 | 6.46 | 6.69 | 5.93 |
| 2021 | 8.36 | 7.14 | 7.31 | 23.33 | 8.36 |
| 2020 | 2.28 | 0.0 | 0.0 | 0.0 | 2.28 |
| 2019 | – | – | – | – | 0.0 |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology